10 completed. 10 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Completed 10 |
| Phase 2 | 1 | Completed 1 |
Follow Synflorix: new trials by email Literature Review of Synflorix trials Research Report on Synflorix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy Infants Pneumosil, Prevenar 13, Synflorix - Pneumonia, Pneumococcal | Phase 3 | Completed | PATH | 660 | 2019-07-18 | 2022-04-20 |
| Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy Infants Pneumosil, Synflorix - Pneumonia, Pneumococcal | Phase 3 | Completed | PATH | 2250 | 2017-06-21 | 2020-07-14 |
| Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, Vietnam PCV10, PCV13 - Pneumococcal Vaccines | Phase 2 / Phase 3 | Completed | Murdoch Childrens Research Institute | 1400 | 2013-09-30 | 2022-09-14 |
| Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A in Healthy Japanese Children Pneumococcal vaccine GSK1024850A, DTPa - Infections, Streptococcal | Phase 3 | Completed | GlaxoSmithKline | 360 | 2009-12-08 | 2019-11-29 |
| Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine GSK1024805A, Prevenar, Infanrix hexa - Infections, Streptococcal, Streptococcus Pneumoniae Vaccines | Phase 3 | Completed | GlaxoSmithKline | 524 | 2008-03-03 | 2021-01-27 |
| Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines Synflorix, Tritanrix-HepB, Hiberix - Infections, Streptococcal | Phase 3 | Completed | GlaxoSmithKline | 756 | 2007-10-22 | 2019-01-14 |
| Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age Synflorix, Infanrix hexa, Rotarix - Infections, Rotavirus | Phase 3 | Completed | GlaxoSmithKline | 230 | 2007-09-18 | 2018-06-08 |
| Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age Synflorix, Infanrix hexa, Rotarix - Infections, Streptococcal, Streptococcus Pneumoniae Vaccines | Phase 3 | Completed | GlaxoSmithKline | 230 | 2007-07-03 | 2020-01-13 |
| Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine. Synflorix, Prevenar, Infanrix hexa - Infections, Streptococcal | Phase 3 | Completed | GlaxoSmithKline | 1200 | 2006-09-25 | 2019-06-10 |
| Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine Synflorix, Infanrix IPV/Hib - Infections, Streptococcal | Phase 3 | Completed | GlaxoSmithKline | 600 | 2006-09-18 | 2019-01-15 |
Streptococcal Infections (6) · Pneumococcal Infections (5) · Pneumonia, Pneumococcal (2) · Haemophilus Infections (1) · Pneumonia (1) · Rotavirus Infections (1)
GlaxoSmithKline (7) · PATH (2) · Murdoch Childrens Research Institute (1)
Poland (3) · Finland (2) · The Gambia (2) · France (1) · Japan (1) · Mexico (1) · Philippines (1) · Taiwan (1) · Vietnam (1)
Ed Clarke (1) · Ed Clarke, MB ChB, PhD (1) · Edward K Mulholland, MBBS, FRACP (1)
PMID 29884695, PMID 30975525, PMID 33516293, PMID 33745731, PMID 34171233, PMID 36638819, PMID 36785850, PMID 41442837
2015 (1)